相关实验视频
Updated: Jun 4, 2025
10:04
Enhancing Tumor Content through Tumor Macrodissection
Published on: February 12, 2022
9.8K
成功治疗患有同时扩散性大B细胞淋巴瘤和霍奇金淋巴瘤的患者:一个病例报告
Jungmin Lee1, Man Hoon Han2, Dong Won Baek1
1Department of Hematology/Oncology, Kyungpook National University Chilgok Hospital, School of Medicine, Kyungpook National University, Daegu, South Korea.
The American journal of case reports
|January 3, 2025
概括
同时诊断的扩散性大B细胞淋巴瘤 (DLBCL) 和霍奇金淋巴瘤 (HL) 是罕见的. 在一个年轻的患者身上,R-CHOP化疗有效地治疗了两种淋巴瘤类型,在移植后实现了完全缓解和持续的无病状态.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 临床病例报告 临床病例报告
背景情况:
- 扩散性大B细胞淋巴瘤 (DLBCL) 和霍奇金淋巴瘤 (HL) 的同时发生非常罕见.
- 标准的第一线治疗方法对于DLBCL (例如R-CHOP) 和HL (例如A-AVD) 有显著的差异,使同时进行治疗的策略复杂化.
- 一名20岁的男性出现了晚期DLBCL和HL,需要量身定制的治疗方法.
研究的目的:
- 报告一个罕见的同时出现DLBCL和HL的罕见病例的成功管理.
- 评估R-CHOP疗法在同时治疗两种淋巴瘤亚型中的疗效.
- 突出巩固性自身干细胞移植 (Auto-SCT) 在实现持久缓解方面的潜在作用.
主要方法:
- 该患者接受了六次R-CHOP化疗周期,其中包括内甲状腺素,用于中枢神经系统预防.
- 在化疗后,患者接受了整合性自主干细胞移植 (自动SCT),使用布苏尔,环胺和埃托胺调节方案.
- 用Deauville得分评估疾病反应,并进行长期随访.
主要成果:
- 患者在六次R-CHOP化疗后实现了完全缓解 (Deauville分数为1),没有显著的不良事件.
- 在这种情况下,R-CHOP疗法证明了对DLBCL和HL的有效性.
- 患者在自动SCT后40个月保持了无疾病状态,没有复发迹象.
结论:
- 对于同时患有DLBCL和HL的患者来说,R-CHOP疗法可以是一个有效的治疗选择.
- 在这种情况下,巩固性前期自身干细胞移植可能是一个有价值的策略,可以实现更深入,更持久的反应.
- 这一案例强调了在已建立的治疗模式下管理罕见的联合淋巴瘤诊断的可行性.
相关概念视频
01:22Bone Marrow Sampling and Transplants
279
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
279
02:50Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K